Skip to content
drillr.ai
Sign up

002793.SZ

Luoxin Pharmaceuticals Group Stock Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 4.66
−6.80%
Ask drillr

  • Aug 20, 2026, 10:06 UTC

    Luoxin Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders of 49.9341 million yuan, up 182.19% year-on-year.

    Source:

  • Aug 7, 2026, 07:50 UTC

    Luoxin Pharmaceutical announced that shares held by shareholders Deyi Chengdu, Deyi Health, and Desheng Health, who collectively hold more than 5% of the company, were judicially frozen, totaling 9,241,258 shares, representing 15.74% of their holdings and 0.85% of the company's total share capital, with the freeze starting on August 5 and expiring on June 15, 2029.

    Source: